Dave Frantze Initial Recipient of Elite Volunteer Award from the Leukemia and Lymphoma Society
The Leukemia & Lymphoma Society (LLS), the world's largest voluntary health agency dedicated to finding cures for blood cancers, recently awarded Dave Frantze a partner in the firm's Kansas City office with the Robert De Villiers Award at LLS’s Volunteer Leadership Conference awards dinner held in Washington, D.C., on May 2, 2017.
The Robert De Villiers Award is the newest of LLS's Elite Awards, which recognize the unwavering dedication of LLS volunteer leaders who embrace LLS's goal to find cures and ensure access to treatments for blood cancer patients. They are influential ambassadors and advocates in their community, and are engaged in multiple aspects of LLS through support of various patient programs and fundraising efforts.
Frantze's commitment to LLS spans over 25 years on both a local and national level. He began serving as a volunteer in 1991, and shortly after became a member of the LLS Mid-America Chapter Board of Trustees. He has served in numerous positions at the local and national level, culminating in his service as the chair of the national board of directors of LLS in 2006-2008. Under Frantze's leadership, LLS established its innovative Therapy Acceleration Program, which works to move therapies from lab to bedside more quickly.
In the following years, Frantze has continued to serve as a volunteer in the Mid-America Chapter. One notable example of this service was co-chairing (with his wife Geri) the Mid-America Chapter Black Tie Ball in 2013. That event remains the only single day event in the chapter's history to exceed $1,000,000 in revenue. Frantze has previously received from LLS the National Chairman's Citation in 2004 and the Spiral of Life Award in 2008.
"I am honored – and humbled – to receive this award. LLS has more than 15 million volunteers who selflessly dedicate their time and energy to find cures. Together, we’re leading the way to a world without blood cancers," said Frantze.
"Dave is a visionary, and when you couple that trait with a willingness to take a calculated risk, great things can happen, as they did with the Therapy Acceleration Program," said Louis J. DeGennaro, Ph.D., LLS’s president and CEO. "Our volunteers make it possible for LLS to accomplish more than any other cancer nonprofit to advance cutting-edge research and cures for patients. Whether you fundraise through a campaign, support patients in your community, or advocate for state and federal policies to benefit patients, you are truly making a difference and helping LLS change the landscape of cancer."
LLS’s Robert de Villiers Award honors and nationally recognizes an individual who has demonstrated through their enduring commitment and extraordinary leadership, their support of the LLS mission to finding cures for blood cancer and to improving the life of patients and their families. Frantze is the initial recipient of this newly-created award.